Commentary: Efficacy of prenatal treatment for toxoplasmosis: A possibility that cannot be ruled out

International Journal of Epidemiology

Volumn 30, Issue 6, 2001, Pages 1315-1316

  Thulliez, P ^a  

^a Institut de Puericulture   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

HEALTH CARE; PREGNANCY;

AMNIOCENTESIS; BRAIN INJURY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; EYE INJURY; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INTRAUTERINE INFECTION; NOTE; PARASITEMIA; PRENATAL CARE; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THIRD TRIMESTER PREGNANCY;

EID: 0035709588     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/30.6.1315     Document Type: Note

References (6)

1. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: Retrospective study of 554 mother-child pairs in Lyon, France
2. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis
3. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis
4. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling
5. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid
6. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice